Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Shares, par value (euro) 0.12 per share
-
Shares outstanding
-
22.4M
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
19.6M
-
Shares change
-
+7.97M
-
Total reported value, excl. options
-
$105M
-
Value change
-
+$42.9M
-
Put/Call ratio
-
0.68
-
Number of buys
-
38
-
Number of sells
-
-39
-
Price
-
$5.39
Significant Holders of CureVac N.V. - Common Shares, par value (euro) 0.12 per share (CVAC) as of Q3 2025
107 filings reported holding CVAC - CureVac N.V. - Common Shares, par value (euro) 0.12 per share as of Q3 2025.
CureVac N.V. - Common Shares, par value (euro) 0.12 per share (CVAC) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.6M shares
of 22.4M outstanding shares and own 87.26% of the company stock.
Largest 10 shareholders include GLAZER CAPITAL, LLC (4.55M shares), ALPINE ASSOCIATES MANAGEMENT INC. (2.3M shares), Qube Research & Technologies Ltd (1.71M shares), BlackRock, Inc. (1.02M shares), AQR Arbitrage LLC (992K shares), WATER ISLAND CAPITAL LLC (762K shares), Magnetar Financial LLC (655K shares), ROYAL BANK OF CANADA (502K shares), Bridgewater Associates, LP (466K shares), and BANK OF AMERICA CORP /DE/ (443K shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.